Optimized RNA Interference Therapeutics Combined with Interleukin-2 mRNA for Treating Hepatitis B Virus Infection

Scientists developed a pan-genotypic and multifunctional small interfering RNA against hepatitis B virus with an efficient delivery system for treating chronic hepatitis B (CHB), and explore combined RNA interference and immune modulatory modalities for better viral control.